Question stringlengths 31 235 | Answer stringlengths 1 1k | Evidence Text listlengths 1 4 | Company Name stringclasses 48
values | Ticker stringclasses 48
values | Filing year float64 2.02k 2.02k | Filing date stringclasses 44
values | CIK float64 2.49k 1.75M | GICS_Sector stringclasses 16
values | URL_HTML stringclasses 51
values | q-id int64 0 2.31k | in-prod float64 0 1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
What was the diluted earnings per share of Amgen Inc for FY 23? | Amgen Inc's diluted earnings per share was $12.49 for FY 23. | [
"The computations for basic and diluted EPS were as follows (in millions, except per-share data):\n Years ended December 31,\n 2023\n 2022\n 2021\n Income (Numerator):\n Net income for basic and diluted EPS\n $\n 6,717 $\n 6,552 $\n 5,893 \n Shares (Denominator):\n Weighted-average shares for basic EPS\n... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 70 | 0 |
How much dividends were paid by Amgen Inc. in FY 23? | Amgen Inc. paid dividends amounting $4,556 million in FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF CASH FLOWS\n Years ended December 31, 2023, 2022 and 2021\n (In millions)\n 2023 2022 2021\n Cash flows from operating activities:\n Net income $ 6,717 $ 6,552 $ 5,893 \n Depreciation, amortization and other 4,071 3,417 3,398 \n Stock-based compensation expense 431 401... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 71 | 0 |
Which operating expense increased most for Amgen Inc. in FY 23? | Cost of sales increased most by 32% for Amgen Inc. in FY 23. | [
"Operating expenses\n Operating expenses were as follows (dollar amounts in millions):\n Year ended December\n 31, 2023 Change\n Year ended December\n 31, 2022 Change\n Year ended December\n 31, 2021\n Cost of sales $ 8,451 32 % $ 6,406 (1)% $ 6,454 \n % of product sales 31.4 % 25.8 % 26.6 %\n % of total r... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 72 | 0 |
What was the percentage change in Amgen Inc.'s total operating expenses in FY 22? | Amgen Inc.'s total operating expenses decreased by 9% in FY 22. | [
"Operating expenses\n Operating expenses were as follows (dollar amounts in millions):\n Year ended December\n 31, 2023 Change\n Year ended December\n 31, 2022 Change\n Year ended December\n 31, 2021\n Cost of sales $ 8,451 32 % $ 6,406 (1)% $ 6,454 \n % of product sales 31.4 % 25.8 % 26.6 %\n % of total r... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 73 | 0 |
How much did Amgen Inc. spend on its R&D in FY 23? | Amgen spent over $4.784 million in its R&D activities in FY 23. | [
"Operating expenses\n Operating expenses were as follows (dollar amounts in millions):\n Year ended December\n 31, 2023 Change\n Year ended December\n 31, 2022 Change\n Year ended December\n 31, 2021\n Cost of sales $ 8,451 32 % $ 6,406 (1)% $ 6,454 \n % of product sales 31.4 % 25.8 % 26.6 %\n % of total r... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 74 | 0 |
Was there any year-on-year change in Amgen Inc.'s selling, general and administrative expenses in FY 23? | Amgen Inc.'s selling, general and administrative expenses increased by 14% in FY 23. | [
"Operating expenses\n Operating expenses were as follows (dollar amounts in millions):\n Year ended December\n 31, 2023 Change\n Year ended December\n 31, 2022 Change\n Year ended December\n 31, 2021\n Cost of sales $ 8,451 32 % $ 6,406 (1)% $ 6,454 \n % of product sales 31.4 % 25.8 % 26.6 %\n % of total r... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 75 | 0 |
What was Amgen Inc.'s cost of sales ratio for FY 23? | Amgen's cost-of-sales ratio was 29.9% for FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 76 | 0 |
What was Amgen Inc.'s return on assets for FY 23? | Amgen Inc.'s return on assets was 0.069 or 6.9% for FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 77 | 0 |
What is Amgen Inc.'s return on equity for FY 23? | Amgen Inc.'s return on equity is 1.07 or 107% for FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 78 | 0 |
What was Amgen Inc.'s asset turnover ratio for FY 23? | Amgen Inc.'s asset turnover ratio for FY 23 was 29.1%. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 79 | 0 |
What was Amgen Inc.'s debt-to-asset ratio for FY 23? | Amgen Inc.'s debt-to-asset ratio was 93.58% for FY 23. | [
"AMGEN INC.\n CONSOLIDATED BALANCE SHEETS\n December 31, 2023 and 2022\n (In millions, except per-share data)\n 2023\n 2022\n ASSETS\n Current assets:\n Cash and cash equivalents\n Marketable securities\n Trade receivables, net\n $\n 10,944 $\n — \n 7,629 \n 1,676 \n 7,268 \n Inventories\n Other curre... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 80 | 0 |
What was Amgen Inc.'s current ratio for FY 23? | Amgen Inc's current ratio was 1.65 for FY 23. | [
"AMGEN INC.\n CONSOLIDATED BALANCE SHEETS\n December 31, 2023 and 2022\n (In millions, except per-share data)\n 2023\n 2022\n ASSETS\n Current assets:\n Cash and cash equivalents\n Marketable securities\n Trade receivables, net\n $\n 10,944 $\n — \n 7,629 \n 1,676 \n 7,268 \n Inventories\n Other curre... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 81 | 0 |
What was Amgen Inc.'s interest coverage ratio for FY 23? | Amgen Inc.'s interest coverage ratio was 2.75 for FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 82 | 0 |
What was Amgen Inc.'s total stock-based compensation expense for FY 23? | Amgen Inc.'s total stock-based compensation expense was $431 million for FY 23. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF CASH FLOWS\n Years ended December 31, 2023, 2022 and 2021\n (In millions)\n 2023 2022 2021\n Cash flows from operating activities:\n Net income $ 6,717 $ 6,552 $ 5,893 \n Depreciation, amortization and other 4,071 3,417 3,398 \n Stock-based compensation expense 431 401... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 83 | 0 |
What were Amgen Inc.'s net trade receivables for FY 23? | Amgen Inc.'s net trade receivables for FY 23 were $7,268 million. | [
"AMGEN INC.\n CONSOLIDATED BALANCE SHEETS\n December 31, 2023 and 2022\n (In millions, except per-share data)\n 2023\n 2022\n ASSETS\n Current assets:\n Cash and cash equivalents\n Marketable securities\n Trade receivables, net\n $\n 10,944 $\n — \n 7,629 \n 1,676 \n 7,268 \n Inventories\n Other curre... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 84 | 0 |
What was Amgen Inc.'s effective tax rate for FY 23? | Amgen Inc.'s effective tax rate for FY 21 was 14.5%. | [
" Nonoperating expenses/income and income taxes\n Nonoperating expenses/income and income taxes were as follows (dollar amounts in millions):\n Years ended December 31,\n 2023\n 2022\n 2021\n Interest expense, net\n $\n Other income (expense), net\n Provision for income taxes\n $\n (2,875)\n 2,833 \n $\... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 85 | 0 |
Was there any change in the effective tax rate of Amgen Inc. in FY 23 as compared to the previous year? | The effective tax rate for Amgen Inc. increased by 3.7% in FY 21. | [
" Nonoperating expenses/income and income taxes\n Nonoperating expenses/income and income taxes were as follows (dollar amounts in millions):\n Years ended December 31,\n 2023\n 2022\n 2021\n Interest expense, net\n $\n Other income (expense), net\n Provision for income taxes\n $\n (2,875)\n 2,833 \n $\... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 86 | 0 |
What was the Amgen Inc. provision for income taxes for FY 23? | Amgen Inc. FY 23 provision for income taxes was $1,138 million. | [
"AMGEN INC.\n CONSOLIDATED STATEMENTS OF INCOME\n Years ended December 31, 2023, 2022 and 2021\n (In millions, except per-share data)\n 2023 2022 2021\n Revenues:\n Product sales $ 26,910 $ 24,801 $ 24,297 \n Other revenues 1,280 1,522 1,682 \n Total revenues 28,190 26,323 25,979 \n Operating expenses:\n Cos... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 87 | 0 |
What was the total lease liability for Amgen Inc. for FY 23? | Amgen Inc.'s total lease liability for FY 23 was $810 million. | [
" The following table summarizes information related to our leases, all of which are classified as operating, included in our Consolidated Balance Sheets (in\n millions):\n December 31,\n Consolidated Balance Sheets locations\n 2023\n 2022\n Assets:\n Other noncurrent assets\n $\n 651 $\n 579 \n Liabiliti... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 88 | 0 |
What was Amgen Inc.'s total net lease cost for FY 23? | Amgen Inc.'s total net lease cost for FY 23 was $180 million. | [
"The components of net lease costs were as follows (in millions):\n Years ended December 31,\n Lease costs\n 2023\n 2022\n 2021\n Operating\n (1)\n Sublease income\n Total net lease costs\n $\n 208 $\n (28)\n 218 $\n (32)\n 237 \n (38)\n $\n ____________\n (1) \n 180 $\n Includes short-term lease... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 89 | 0 |
How much of Amgen Inc.'s lease liabilities will be maturing in FY 24? | Amgen's lease liabilities of $138 million will be maturing in FY 24. | [
"Maturities of lease liabilities as of December 31, 2023, were as follows (in millions):\n Maturity dates\n Amounts\n 2024\n $\n 2025\n 2026\n 138 \n 121 \n 109 \n 2027\n 2028\n 95 \n 74 \n Thereafter\n Total lease payments\n (1)\n 440 \n 977 \n Less imputed interest\n Present value of lease liabilitie... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 90 | 0 |
What was Amgen Inc.'s sublease income for FY 23? | Amgen Inc.'s sublease income for FY 23 was -$28 million. | [
"The components of net lease costs were as follows (in millions):\n Years ended December 31,\n Lease costs\n 2023\n 2022\n 2021\n Operating\n (1)\n Sublease income\n Total net lease costs\n $\n 208 $\n (28)\n 218 $\n (32)\n 237 \n (38)\n $\n ____________\n (1) \n 180 $\n Includes short-term lease... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 91 | 0 |
What were Amgen Inc. accounts payable as of December 31, 2023? | Amgen Inc. accounts payable amounted to $1,590 million as of December 31, 2023. | [
"AMGEN INC.\n CONSOLIDATED BALANCE SHEETS\n December 31, 2023 and 2022\n (In millions, except per-share data)\n 2023\n 2022\n ASSETS\n Current assets:\n Cash and cash equivalents\n Marketable securities\n Trade receivables, net\n $\n 10,944 $\n — \n 7,629 \n 1,676 \n 7,268 \n Inventories\n Other curre... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 92 | 0 |
What was Amgen Inc.'s current portion of long-term debt as of December 31, 2023? | Amgen Inc.'s current portion of long-term debt was $1,443 million as of December 31, 2023. | [
"AMGEN INC.\n CONSOLIDATED BALANCE SHEETS\n December 31, 2023 and 2022\n (In millions, except per-share data)\n 2023\n 2022\n ASSETS\n Current assets:\n Cash and cash equivalents\n Marketable securities\n Trade receivables, net\n $\n 10,944 $\n — \n 7,629 \n 1,676 \n 7,268 \n Inventories\n Other curre... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 93 | 0 |
What were Amgen Inc.'s net intangible assets for FY 23? | Amgen Inc.'s net intangible assets for FY 23 totaled at $32,641 million. | [
" Other intangible assets\n Other intangible assets consisted of the following (in millions):\n December 31,\n 2023 2022\n \n Gross carrying amounts\n Accumulated amortization\n Other intangible assets, net\n Gross carrying amounts\n Accumulated amortization\n Other intangible assets, net\n Finite-lived i... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 94 | 0 |
What was the accumulated amortization cost for Amgen Inc.'s intangible assets for FY 23? | The accumulated amortization cost for Amgen Inc.'s intangible assets for FY 23 was $23,806 million. | [
" Other intangible assets\n Other intangible assets consisted of the following (in millions):\n December 31,\n 2023 2022\n \n Gross carrying amounts\n Accumulated amortization\n Other intangible assets, net\n Gross carrying amounts\n Accumulated amortization\n Other intangible assets, net\n Finite-lived i... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 95 | 0 |
What were the total available-for-sale investments for Amgen Inc. as of FY 23? | Amgen Inc.'s total available-for-sale investments were $10,404 million in FY 23. | [
"Available-for-sale investments\n The amortized cost, gross unrealized gains, gross unrealized losses and fair values of interest-bearing securities, which are considered available-for-sale,\n by type of security were as follows (in millions):\n Types of securities as of December 31, 2023\n Amortized \n cost\n ... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 96 | 0 |
Which was the major investment security for Amgen Inc. as of December 31, 2023? | As of December 31, 2023, Amgen Inc. had the majority of its investments amounting $2,659 million in money market securities. | [
" Available-for-sale investments\n The amortized cost, gross unrealized gains, gross unrealized losses and fair values of interest-bearing securities, which are considered available-for-sale,\n by type of security were as follows (in millions):\n Types of securities as of December 31, 2023\n Amortized \n cost\n... | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 97 | 0 |
What was Amgen Inc.'s total amount of inventories for FY 23? | Amgen Inc.'s total inventories for FY 23 amounted to $9,518 million. | [
" 11. Inventories\n Inventories consisted of the following (in millions):\n Raw materials\n December 31,\n 2023\n 2022\n $\n Work in process\n Finished goods\n 993 $\n 5,747 \n 828 \n 3,098 \n 2,778 \n 1,004 \n Total inventories\n (1)\n $\n 9,518 $ 4,930 "
] | AMGEN INC | AMGN | 2,024 | 2024-02-14 | 318,154 | Healthcare | https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/amgn-20231231.htm | 98 | 0 |
What was the total revenue in the fiscal year 2023 for CVS Health Corp? | The revenue for the fiscal year 2023 was $ 357,776 million for CVS Health Corp | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 99 | 0 |
Which revenue line item had the highest revenue in all the three years combined , FY 2021, FY 2022 and FY 2023, for CVS Health Corp? | The revenue line item with the highest revenue in all the three years combined was Products for CVS Health Corp | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 100 | 0 |
What is the percentage of Premiums revenue in terms of total revenue for the fiscal year 2023 for CVS Health Corp? | The percentage of premiums revenue in terms of total revenue for CVS Health Corp was 27.72% | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 101 | 0 |
What was the consolidated total revenue for front store in the fiscal year 2023 for CVS Health Corp? | The consolidated total for the fiscal year 2023 for Front store was $22,458 for CVS Health Corp | [
"Disaggregation of Revenue The following table disaggregates the Company’s revenue by major source in each segment for the years ended December 31, 2023, 2022 and 2021: In millions Health Care Benefits Health Services Pharmacy & Consumer Wellness Corporate/ Other Intersegment Eliminations Consolidated Totals 2023 M... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 102 | 0 |
How much did the consolidated total revenue grow from fiscal year 2022 to fiscal year 2023 for Pharmacy for CVS Health Corp? | The consolidated total revenue grew from fiscal year 2022 to fiscal year 2023 for Pharmacy for CVS Health Corp by 8.9% | [
"Disaggregation of Revenue The following table disaggregates the Company’s revenue by major source in each segment for the years ended December 31, 2023, 2022 and 2021: In millions Health Care Benefits Health Services Pharmacy & Consumer Wellness Corporate/ Other Intersegment Eliminations Consolidated Totals 2023 M... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 103 | 0 |
What was the CAGR for Product for CVS Health Corp for the fiscal year 2023 from fiscal year 2021? | The CAGR for total revenues was 6.36% for CVS Health Corp for the fiscal year 2023 from the fiscal year 2021 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 104 | 0 |
Was the CAGR from 2021 to 2023 for Product higher than the Year over year growth in Product from fiscal year 2022 to fiscal year 2023 for CVS Health Corp? | No, the Year over year growth from fiscal year 2022 to fiscal year 2023 was greater than the CAGR from 2021 to 2023 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 105 | 0 |
Which revenue line item had the highest increase year over year from fiscal year 2022 to fiscal year 2023 for CVS Health Corp? | The highest year over year growth was observed in Net Investments income | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 106 | 0 |
What was net investment income in the fiscal year 2022 for CVS Health Corp? | The net investment income in the fiscal year 2022 for CVS Health Corp was $838 million | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 107 | 0 |
Which business segment revenue had the highest revenue in the fiscal year 2023 for CVS Health Corp? | Health services had the highest revenue in the fiscal year 2023 with $186,843 million in total revenues | [
"Disaggregation of Revenue The following table disaggregates the Company’s revenue by major source in each segment for the years ended December 31, 2023, 2022 and 2021: In millions Health Care Benefits Health Services Pharmacy & Consumer Wellness Corporate/ Other Intersegment Eliminations Consolidated Totals 2023 M... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 108 | 0 |
What was the gross profit margin for fiscal year 2023 for CVS Health Corp? | The gross profit margin for fiscal year 2023 was 39.32% | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 109 | 0 |
Did the gross profit margin increase or decrease between fiscal year 2022 and fiscal year 2023 for CVS Health Corp? | Yes, The gross profit margin increased from 38.94% in fiscal year 2022 to 39.32% in fiscal year 2023. | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 110 | 0 |
What was the Cost of products sold in the fiscal year 2021 for CVS Health Corp? | The cost of products sold in fiscal year 2021 was $175,803 million | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 111 | 0 |
What was the operating income or loss for the fiscal year 2023 for CVS Health Corp? | The operating income or loss for the fiscal year 2023 was $13,743 million | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 112 | 0 |
What was the operating profit margin in fiscal year 2023 for CVS Health Corp? | The operating profit margin in fiscal year 2023 was 3.84% | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 113 | 0 |
Did the operating profit margin improve or worsen between fiscal year 2022 and fiscal year 2023 for CVS Health Corp? | No, the operating profit margin decreased from 2.46% in fiscal year 2022 to 3.84% in fiscal year 2023 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 114 | 0 |
What was the basic net income per share attributable to CVS health Corp for the fiscal year 2023? | The basic net income per share attributable to CVS health Corp for the fiscal year 2023 was $6.49 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 115 | 0 |
What was the diluted net income per share attributable to CVS health Corp for the fiscal year 2023? | The diluted net income per share attributable to CVS health Corp for the fiscal year 2023 was $6.47 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 116 | 0 |
What was the YoY change in basic net income per share attributable to CVS health Corp for the fiscal year 2023 from 2022? | the YoY change in basic net income per share attributable to CVS health Corp for the fiscal year 2023 from 2022 was 97.26% | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 117 | 0 |
What was the dividend declared per share in fiscal year 2023 for CVS Health Corp? | The dividend declared per in fiscal year 2023 for CVS Health Corp was $2.42 per share | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 118 | 0 |
What was the change in the dividend declared per share YoY, from fiscal year 2022 to fiscal year 2023, for CVS Health Corp? | The change in the dividend declared per share YoY, from fiscal year 2022 to fiscal year 2023, for CVS Health Corp was 10% | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 119 | 0 |
What was the total operating costs for the fiscal year 2023 for CVS Health Corp? | The total operating costs for the fiscal year 2023 for CVS Health Corp was $344,033 million | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 120 | 0 |
What was the YoY change in the total operating costs from the fiscal year 2022 to fiscal year 2023 for CVS Health Corp? | The total operating costs increased YoY by 9.39%. | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 121 | 0 |
Which operating cost line item was the highest in fiscal year 2023 apart from Cost of Products sold for CVS Health Corp? | Health Care Costs was the highest after cost of products at $86,247 million | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 122 | 0 |
What was the value of experience-rated products in the company's investment portfolio for the fiscal year 2023 for CVS Health Corp? | The value of experience-rated products in the company's investment portfolio for the fiscal year 2023 for CVS Health Corp was $723 million. | [
"Investments\nThe Company’s investment portfolio supported the following products at December 31, 2023 and 2022:\nIn millions 2023 2022\nExperience-rated products $ 723 $ 744\nRemaining products 25,555 23,147\nTotal investments $ 26,278 $ 23,891"
] | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 123 | 0 |
What was the Quick ratio for the fiscal year 2023 for CVS Health Corp? | The quick ratio for CVS Health Corp for the fiscal year 2023 was 0.63 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 124 | 0 |
Did the Quick ratio change YoY from fiscal year 2022 to fiscal year 2023 for CVS Health Corp? | Yes, The Quick ratio slightly changed YoY from 0.67 in fiscal year 2022 to 0.63 in fiscal year 2023 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 125 | 0 |
What was the current ratio for the fiscal year 2023 for CVS Health Corp? | The current ratio for CVS Health Corp for the fiscal year 2023 was 0.87 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 126 | 0 |
What was the change YoY in percentage terms in the current ratio for fiscal year 2023 for CVS Health Corp? | The YoY change in percentage terms from fiscal year 2022 to fiscal year 2023 for CVS Health Corp was -8.42% | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 127 | 0 |
What was the debt to assets ratio for the fiscal year 2023 for CVS Health Corp? | The debt to assets ratio for CVS Health Corp for the fiscal year 2023 was 0.7 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 128 | 0 |
What was the debt to equity ratio for the fiscal year 2023 for CVS Health Corp? | The debt to equity ratio for CVS Health Corp for the fiscal year 2023 was 2.26 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 129 | 0 |
What was the debt to total capital ratio for the fiscal year 2023 for CVS Health Corp? | The debt to total capital ratio for CVS Health Corp for the fiscal year 2023 was 0.69 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 130 | 0 |
What was the Asset turnover ratio for the fiscal year 2023 for CVS Health Corp? | The Asset turnover ratio for the fiscal year 2023 was 1.5 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 131 | 0 |
What was the ROE for the fiscal year 2023 for CVS Health Corp? | The ROE for the fiscal year 2023 for CVS Health Corp was 11.24% | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 132 | 0 |
What was the debt service coverage ratio for the fiscal year 2023 for CVS Health Corp? | The debt service coverage ratio for the fiscal year 2023 for CVS Health Corp was 0.17 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 133 | 0 |
What was the interest coverage ratio for the fiscal year 2023 for CVS Health Corp? | The interest coverage ratio for the fiscal year 2023 for CVS Health Corp was 5.17 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 134 | 0 |
What was the Capital intensity ratio for the fiscal year 2023 for CVS Health Corp? | The Capital intensity ratio for the fiscal year 2023 for CVS Health Corp was 0.67 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 135 | 0 |
What was the value of the preferred stock issued by CVS Health Corp for fiscal year 2023? | The value of the preferred stock issued by CVS Health Corp for fiscal year 2023 was $0 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 136 | 0 |
How many common stock shares were authorized for CVS Health Corp for fiscal year 2023? | The common stock shares authorized for CVS Health Corp for fiscal year 2023 was 3,200 shares. | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 137 | 0 |
What was the Long term investments for the fiscal year ending 2023 for CVS Health Corp? | The Long term investments for the fiscal year ending 2023 for CVS Health Corp was $23,019 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 138 | 0 |
What was the YoY % change in the long-term investments for CVS Health Corp from fiscal year 2022 to fiscal year 2023? | The YoY change in the long-term investments for CVS Health Corp from fiscal year 2022 to fiscal year 2023 was an increase of 9.12%. | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 139 | 0 |
What was the total of inventories in fiscal year 2023 for CVS Health Corp? | The total of inventories in fiscal year 2023 for CVS Health Corp was $18,025 million | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 140 | 0 |
What was the YoY % change in inventories for CVS Health Corp the fiscal year 2022 to fiscal year 2023? | The YoY change in inventories for CVS Health Corp from the fiscal year 2022 to fiscal year 2023 was a decrease of 5.58%. | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 141 | 0 |
What were the total intangible assets, net for CVS Health Corp for the fiscal year 2023? | The total intangible assets, net for CVS Health Corp for the fiscal year 2023 was $29,234 | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 142 | 0 |
What was the YoY % change in intangible assets, net for CVS Health Corp from fiscal year 2022 to fiscal year 2023? | The YoY % change in intangible assets, net for CVS Health Corp from fiscal year 2022 to fiscal year 2023 was an increase of 17.86% | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 143 | 0 |
Was there any goodwill impairment expense charged for the fiscal year 2023 for CVS Health Corp? | No, there was no goodwill impairment charged for the fiscal year 2023 | [
"Consolidated Statements of Operations\nFor the Years Ended December 31,\nIn millions, except per share amounts 2023 2022 2021\nRevenues:\nProducts $ 245,138 $ 226,616 $ 203,738\nPremiums 99,192 85,330 76,132\nServices 12,293 9,683 11,042\nNet investment income 1,153 838 1,199\nTotal revenues 357,776 322,467 292,11... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 144 | 0 |
How much was the long-term debt for CVS Health Corp for fiscal year 2023? | The long-term debt for CVS Health Corp for fiscal year 2023 was $58,638 million | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 145 | 0 |
What was the YoY % change in long-term debt for CVS Health Corp for the fiscal year 2023 to fiscal year 2022 ? | The long-term debt for CVS Health Corp showed a YoY change of 16.17% for the fiscal year 2023 from the fiscal year 2022 for CVS Health Corp. | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 146 | 0 |
How much was the Long-term operating lease liabilities for CVS Health Corp for fiscal year 2023? | The Long-term operating lease liabilities for CVS Health Corp for fiscal year 2023 was $16,034 million | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 147 | 0 |
What was the YoY % change in Long-term operating lease liabilities for CVS Health Corp for the fiscal year 2023 from fiscal year 2022? | The Long-term operating lease liabilities for CVS Health Corp for the fiscal year 2023 in comparison to the fiscal year 2022 showed a change of negative 0.45% | [
"Consolidated Balance Sheets\nAt December 31,\nIn millions, except per share amounts 2023 2022\nAssets:\nCash and cash equivalents $ 8,196 $ 12,945\nInvestments 3,259 2,778\nAccounts receivable, net 35,227 27,276\nInventories 18,025 19,090\nAssets held for sale — 908\nOther current assets 3,151 2,636\nTotal current... | CVS HEALTH Corp | CVS | 2,024 | 2024-02-07 | 64,803 | Healthcare | https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/cvs-20231231.htm | 148 | 0 |
What is the total operating revenue of Verizon Communications Inc. for the year ending Decmber 31st, 2023? | The total operating revenue for Verizon Communications for FY2023 was $133,974 million. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 149 | 0 |
What is the YoY growth of Verizon Communications Inc.'s total operating reveue between FY2022 and FY2023? | Verizon's total operating revenue between FY2022 and FY2023 declined by 2.09% | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 150 | 0 |
What is the operating revenue of Verizon Communications Inc. from Services for the FY2023? | The operating revenue for Verizon Communications from Services for FY2023 was $109,652 million. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 151 | 0 |
What is the operating revenue of Verizon Communications Inc. from Wireless equipments for the FY2022? | The operating revenue for Verizon Communications from wireless equipment for FY2022 was $27,210 million. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 152 | 0 |
What was Verizon Communications Inc's total cost of revenue for FY 2023? | Verizon Communications Inc's total cost of revenue for FY 2023 was $54,887 million | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 153 | 0 |
What was Verizon Communications Inc.'s Gross Margin for FY 2021? | Verizon Communications Inc's Gross Margin for FY 2021 was $77,312 million | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 154 | 0 |
How much were the Depreciation and amortization expenses for Verizon Communications Inc. in FY2023? | The Depreciation and ammortization expenses for Verizon in FY2023 were $17,624 million | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 155 | 0 |
How much were the Selling, general and administrative costs for Verizon Communications Inc. in FY2022? | Verizon Communications Inc's Selling, General and Administrative cost for FY 2022 was $30,136 million | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 156 | 0 |
How much was the goodwill impairment for Verizon Communications Inc. in FY2023? | The goodwill impairment for Verizon in FY2023 was $5,841 million | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 157 | 0 |
How much change did Verizon Communications Inc.'s cost of wireless equipment observe in percentage terms from FY2022 to FY2023? | Verizon's cost of wireless equipment fell by 12.16% to $26,787 million from FY2022 to FY2023 | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 158 | 0 |
What is the percentage increase/decrease in the total operating revenue from FY2021 to FY2022 for Verizon Communications Inc.? | The percentage increase in Verizon Communications Inc's total operating revenue from FY2021 TO FY2022 was 2.41%. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 159 | 0 |
What is Verizon Communications Inc.'s basic EPS for FY2023? | Verizon Communications Inc's basic EPS for FY2023 was $2.76. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 160 | 0 |
What is Verizon Communications Inc.'s diluted EPS for FY2021? | Verizon Communications Inc's diluted EPS for FY2021 was $5.32. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 161 | 0 |
What is the YoY growth between FY21 and FY23, on the basic EPS of Verizon Communications Inc.? | Verizon Communication Inc's basic EPS fell by 48.12% from FY2021 to FY2023. | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 162 | 0 |
What is the quick ratio of Verizon Communications Inc. for FY2023? | The quick ratio for Verizon Communication for FY2023 was 0.653 | [
"Consolidated Balance Sheets Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) At December 31, 2023 2022 Assets Current assets Cash and cash equivalents $ 2,065 $ 2,605 Accounts receivable 26,102 25,332 Less Allowance for credit losses 1,017 826 Accounts receivable, net 25... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 163 | 0 |
By how much has the quick ratio increased/decreased in FY2023 from FY2022? | Verizon's quick ratio was 0.707 in FY2022. It has decreased by 7.64% in FY2023 | [
"Consolidated Balance Sheets Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) At December 31, 2023 2022 Assets Current assets Cash and cash equivalents $ 2,065 $ 2,605 Accounts receivable 26,102 25,332 Less Allowance for credit losses 1,017 826 Accounts receivable, net 25... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 164 | 0 |
What was the current ratio of Verizon Communications Inc. for FY2023? | The current ratio for Verizon Communication for FY2023 was 0.692 | [
"Consolidated Balance Sheets Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) At December 31, 2023 2022 Assets Current assets Cash and cash equivalents $ 2,065 $ 2,605 Accounts receivable 26,102 25,332 Less Allowance for credit losses 1,017 826 Accounts receivable, net 25... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 165 | 0 |
What was the Day Sales Outstanding for Verizon Communications Inc. in FY2023? | Verizon Communication's DSO for FY2023 comes out to be 70.06 days | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 166 | 0 |
Has the DSO increased / decreased from FY2022? If so, by how much? | The DSO for Verizon increased by 2.48 days from FY2022 | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 167 | 0 |
What was the Days Payables Outstanding for Verizon Communications Inc. in FY2023? | The Days Payables Outstanding ratio for Verizon in FY2023 was 155.96 days | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 168 | 0 |
What was the Days Inventory Outstanding for Verizon Communications Inc. in FY2023? | Verizon's Days Inventory Outstanding in FY2023 was 13.68 days | [
"Consolidated Statements of Income Verizon Communications Inc. and Subsidiaries (dollars in millions, except per share amounts) Years Ended December 31, 2023 2022 2021 Operating Revenues Service revenues and other $ 109,652 $ 109,625 $ 110,449 Wireless equipment revenues 24,322 27,210 23,164 Total Operating Revenue... | VERIZON COMMUNICATIONS INC | VZ | 2,024 | 2024-02-09 | 732,712 | Communication Services | https://www.sec.gov/Archives/edgar/data/732712/000073271224000010/vz-20231231.htm | 169 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.